Ariel Rubashkin

Ariel Rubashkin

Director/Board Member at ENDYMED LTD
48 year
Health Technology
Consumer Services
Finance

Profile

Ariel Rubashkin is an Independent Director at EndyMed Ltd. and a Managing Director at Syneron GmbH.
He is also a Director at Allium Ltd., Truleaf Medical Ltd., and Allevetix Medical Ltd. Mr. Rubashkin was previously the Chief Executive Officer at Allmed Solutions Ltd. from 2014 to 2022 and the Global Vice President-Finance at Syneron Medical Ltd. from 2007 to 2014.
He also worked as a Controller at Plastro Gvat.
Mr. Rubashkin holds an MBA from Tel-Aviv University and an undergraduate degree from the University of Haifa.

Ariel Rubashkin active positions

CompaniesPositionStart
ENDYMED LTD Director/Board Member 05/01/2021
Chief Executive Officer 19/10/2011
Director/Board Member 01/10/2019
Director/Board Member 01/10/2019
Director/Board Member 01/10/2019

Former positions of Ariel Rubashkin

CompaniesPositionEnd
ALLMED SOLUTIONS LTD Chief Executive Officer 28/02/2022
SYNERON MEDICAL LTD. Corporate Officer/Principal 01/01/2014
Comptroller/Controller/Auditor 02/01/1990
See the detail of Ariel Rubashkin's experience

Training of Ariel Rubashkin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Ariel Rubashkin
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!